NU-MED Centrum Diagnostyki i Terapii Onkologicznej

Tomaszów Mazowiecki 97-200

1 studies enrolling now · 2 studies all time

What they study most

HER2-positive Breast Cancer, Urothelial Carcinoma

Studies at this site

• RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive — Recruiting now
• Study of Atezolizumab as Monotherapy and in Combination With Platinum-Based Chemotherapy in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma — Completed